Your browser doesn't support javascript.
loading
Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma.
Kaddu-Mulindwa, Dominic; Gödel, Philipp; Kutsch, Nadine; Heger, Jan-Michel; Scheid, Christof; Borchmann, Peter; Holtick, Udo; Held, Gerhard; Thurner, Lorenz; Bewarder, Moritz; Rixecker, Torben; Bittenbring, Joerg-Thomas.
Afiliação
  • Kaddu-Mulindwa D; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany. Electronic address: dominic.kaddu@uks.eu.
  • Gödel P; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
  • Kutsch N; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
  • Heger JM; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
  • Scheid C; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
  • Borchmann P; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
  • Holtick U; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
  • Held G; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany.
  • Thurner L; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany.
  • Bewarder M; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany.
  • Rixecker T; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany.
  • Bittenbring JT; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany.
Clin Lymphoma Myeloma Leuk ; 22(7): e498-e506, 2022 07.
Article em En | MEDLINE | ID: mdl-35094950
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Transplante de Células-Tronco Hematopoéticas / Linfoma Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Transplante de Células-Tronco Hematopoéticas / Linfoma Idioma: En Ano de publicação: 2022 Tipo de documento: Article